AbbVie

Open: 136.15 Close: 135.28 Change: -0.87

Try an AI to get informed about investing in AbbVie.

How much time have you spent trying to decide whether investing in AbbVie? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, employee, …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie stock sinks 5.1% premarket after Q1 profit missed expectations. European Commission approved Rinvoq as the first oral Janus Kinase (JAK) inhibitor for the treatment of Crohns disease. Dividends will be paid on the closing date of Abbvies pending acquisition.

Today's News

AbbVie stock sinks 5.1% premarket after Q1 profit missed expectations. Abbvie on track for biggest decline in about three years as newer drug sales lag estimates. Dividends will be paid on the closing date of AbbVies pending acquisition of Allergan. European Commission approved Rinvoq as the first oral Janus Kinase (JAK) inhibitor for the treatment of Crohns disease. Full-Year 2023 Outlook AbbVie is raising its adjusted diluted EPS guidance for the full year 2023 from $10.62 - $11.02 to $10.72 -  $11.12. Management believes non-GAAP financial measures provide useful information. upadacitinib (rinvoq®) achieved primary and key secondary endpoints in first phase 3 induction study in patients with crohns disease. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties. The Yes link below will take you out of the AbbVie family of websites. The inclusion of any link does not imply endorsement of the linked site. AbbVie (ABBV) has boosted its dividend by a whopping 270% since its spin-off from Abbott. Dividend Aristocrats are a group of stocks in the S&P 500 that have been a dividend aristocrat. Risankizumab (Skyrizi) achieves statistical significance with its primary endpoint of clinical remission in a late-stage study as a maintenance treatment for ulcerative colitis. AbbVie shareholders are doubtless bracing themselves. AbbVie (ABBV) closed at $137.82, marking a -0.59% move from the previous day. The European Medicines Agencies Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of atogepant for the prophylaxis of migraine. AbbVie employees volunteer during 8th annual week of possibilities to support communities globally. Week of Possibilities brings more than 14,000 employees together. AbbVie kicks off its eighth Week of Possibilities today with more than 14,000 employees volunteering in more than 50 countries and territories to serve local communities around the world. From June 26 to 30 employees will work with trusted community partners to complete hands-on projects. AbbVie kicks off its eighth Week of Possibilities today with more than 14,000 employees volunteering in more than 50 countries and territories to serve local communities around the world. The annual volunteer initiative is aligned to Abbvie philanthropy strategy. AbbVie employees will work with trusted community partners to complete hands-on projects from June 26 to 30. Week of Possibilities is aligned to Abbvie philanthropy strategy. Abu Dhabi Department of Health Forms Strategic Partnership with M42, AbbVie. Partnership aims to advance precision medicine in diagnosis and treatment. AbbVie employees will volunteer for Week of Possibilities projects in 15 cities across the U.S., in addition to more than 50 countries and territories around the world, where thousands of Abbvie employees volunteer. Volunteers will help clean up three local schools to prepare for students to return to class. AbbVie Inc. has signed a memorandum of understanding with integrated healthcare company M42 and Abbvie Biopharmaceuticals to advance personalised medicine and genomics in Abu Dhabi. The average PE ratio for ABBV stock over the past 3 years is 26.6. The average P/E ratio for today is 31.91. AbbVie Incis Overvalued by 9%. AbbVie employees volunteer during 8th annual week of possibilities to support communities globally. Abbvie employees will work with trusted community partners to complete hands-on projects. AbbVie Inc. (ABBV) stock price, quote & news - stock analysis. Analyst Consensus: Buy Stock Forecasts. Analyst consensus: Buy stock forecasts. AbbVie to Present at Goldman Sachs 44th Annual Global Healthcare Conference on June 14, 2023. Company announced European Medicines Agencies Committee for Medicinal Products for Human Use (CHMP) has approved Genmab-AbbVies blood cancer therapy.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

Are looking for the most relevant information about AbbVie? Investor spend a lot of time searching for information to make investment decisions in AbbVie. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, employee, volunteer, community, stock, Abbvie, Week, and the most common words in the summary are: abbvie, stock, news, market, inc, abbv, year, . One of the sentences in the summary was: Dividends will be paid on the closing date of Abbvies pending acquisition.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #news #market #inc #abbv #year.